Top

Annals of Hematology

Published in:

01-09-2010 | Letter to the Editor

Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report

Authors: Stefano Sansone, Johanna Rottensteiner, Judith Stocker, Carlo Rosanelli, Christian Josef Wiedermann

Published in: Annals of Hematology | Issue 9/2010

Excerpt

Dear Editor, …

Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371:64–74CrossRefPubMed

Luzzatto L, Metha A, Vulliamy T (2001) Glucose 6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, Columbus, pp 4517–4553

Associazione Italiana di Favismo-Deficit di G6PD (2009) http://www.g6pd.org/favism/english/index.mvc?pgid=avoid. Accessed 11 December 2009

Glader B (2009) Diagnosis and treatment of glucose-6-phosphate dehydrogenase deficiency. In: Schrier SL, Mahoney DH, eds. UpToDate. http://www.uptodate.com/online/content/topic.do?topicKey=red_cell/21725&selectedTitle=1∼150&source=search_result. Accessed 11 December 2009

Jordan K, Kellner O, Kegel T, Schmoll HJ, Grothey A (2004) Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancers. Clin Colorectal Cancer 4:46–50CrossRefPubMed

Beutler E (1994) G6PD deficiency. Blood 84:3613–3636PubMed

Herman J, Ben-Meir S (1975) Overt hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a survey in general practice. Isr J Med Sci 11:340–346PubMed

Reinke CM, Thomas JK, Graves AH (1996) Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review. J Pharm Technol 11:256–262, quiz 293-295PubMed

Beutler E, Duparc S, G6PD Deficiency Working Group (2007) Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg 77:779–789PubMed

10.

Gaetani GF, Gallano S, Miglino M, Canepa L, Ferrarie AM (1991) Absence of hemolytic potential of ofloxacin toward dehydrogenase deficient erythrocytes. Curr Ther Res 42:329–334

11.

Norfloxacin: Drug information. Copyright 1978-2009 Lexi-Comp, Inc. (2009) http://www.uptodate.com/online/content/topic.do;jsessionid=63A4FDC99FB1FD4EC3284871C6C67EFE.1003?topicKey=drug_l_z/183660&drug=true. Accessed 11 December 2009

12.

Andrews PA, Robinson GT (1999) Intravascular haemolysis and interstitial nephritis in association with ciprofloxacin. Nephron 83:359–360CrossRefPubMed

13.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245PubMed

14.

Lim F, Wulliamy T, Abdalla SH (2005) An Ashkenazi Jewish woman presenting with favism. J Clin Pathol 58:317–319CrossRefPubMed

15.

Italian Ciprofloxacin Package Insert (2009) http://www.paginesanitarie.com/skfarmaci/monografia%20di%20CIPROXIN%206CPR%20RIV%20500MG.htm. Accessed 28 December 2009

16.

US Ciprofloxacin Package Insert (2009) http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019537s073,020780s030lbl.pdf. Accessed 28 December 2009

Title: Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report
Authors: Stefano Sansone
Johanna Rottensteiner
Judith Stocker
Carlo Rosanelli
Christian Josef Wiedermann
Publication date: 01-09-2010
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 9/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-010-0903-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2010

Can decreasing smoking prevalence reduce leukemia mortality?

Serological response to influenza vaccine after hematopoetic stem cell transplantation

Two case reports of non-secretary-Ig types of lymphoplasmacytic lymphoma (LPL)

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials